Trust CO Of Oklahoma Gilead Sciences, Inc. Transaction History

Trust CO Of Oklahoma

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 10, 2019	SELL	$62.53 - $70.05 $224,295 - $251,269	-3,587 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $226,540 - $295,618	-3,742 Reduced 51.06%	3,587 $224,000
Q3 2018 Oct 12, 2018	SELL	$71.28 - $78.92 $4,205 - $4,656	-59 Reduced 0.8%	7,329 $0
Q2 2018 Jul 16, 2018	SELL	$64.88 - $75.68 $60,273 - $70,306	-929 Reduced 11.17%	7,388 $0
Q1 2018 Apr 20, 2018	SELL	$72.84 - $88.8 $10,488 - $12,787	-144 Reduced 1.7%	8,317 $0
Q4 2017 Jan 11, 2018	SELL	$71.15 - $83.52 $19,210 - $22,550	-270 Reduced 3.09%	8,461 $0
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $629,592 - $746,238	8,731	8,731 $0

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Trust CO Of Oklahoma, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Oklahoma with notifications on news.